Qube Research & Technologies (QRT)’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-201,587
Closed -$4.02M 3211
2022
Q3
$4.02M Buy
201,587
+166,372
+472% +$2.19M 0.02% 680
2022
Q2
$243K Sell
35,215
-54,624
-61% -$383K ﹤0.01% 1656
2022
Q1
$836K Buy
89,839
+76,844
+591% +$818K 0.01% 1258
2021
Q4
$185K Buy
+12,995
New +$225K ﹤0.01% 2002

Qube Research & Technologies (QRT)'s FMTX Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 201,587 shares — an estimated $4.02M sold.

Qube Research & Technologies (QRT) first reported a position in FMTX in Q4 2021 and held it in 4 quarters. The position peaked at $4.02M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 201,587 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $4.02M.
  • Qube Research & Technologies (QRT) first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.02M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.